Schizophrenia Disorder: Clinical Trials

2 trials for Schizophrenia Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 1, Recruiting 1

Follow Schizophrenia Disorder: new trials by email Literature Review of Schizophrenia Disorder trials Research Report on Schizophrenia Disorder

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Semaglutide + TAU, Placebo + TAU - Schizophrenia Disorder, Metabolic Syndrome
Phase 3Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar6002026-12-012026-08-18
Cognitive Strategies in Early Psychosis 2
Modafinil, D-serine solution, Placebo - Psychosis, Schizophrenia Disorder
Phase 3RecruitingUniversity of Minnesota242026-07-172026-07-23

Narrower conditions

Schizophrenia (2)  ·  Insulin Resistance (1)  ·  Mental Disorders (1)  ·  Metabolic Syndrome (1)  ·  Psychotic Disorders (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (2)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Modafinil (1)  ·  semaglutide (1)

Sponsors

All India Institute of Medical Sciences, Bhubaneswar (1)  ·  University of Minnesota (1)

Countries

United States (1)

Top investigators

Caroline Demro, Ph.D. (1)  ·  Sophia Vinogradov, MD (1)

NIH funding

P50MH119569 (1)